Physician

David L Kerstetter, M.D.

According to 2025 Medicare claims, David Kerstetter, M.D. (NPI: 1619994076) practices gastroenterology in the Altoona, PA market, with the plurality of this provider's patient population coming from Blair, PA. This provider's primary affiliated billing organization is REGIONAL GASTROENTEROLOGY ASSOCIATES OF LANCASTER, LTD. (NPI: 1154422806; TIN: 232812220) and primary practice location at 17601-2644. Kerstetter is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Kerstetter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 403 traditional Medicare patients, billed 5,369 HCPCS/CPT codes, and received $151,174 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 591 prescription claims across 236 beneficiaries totaling $44,724 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 10 records totaling $211. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $231,742 to $44,724. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	793	2,467	$176,842
2016	795	3,250	$179,172
2017	855	3,511	$205,230
2018	895	3,355	$217,222
2019	869	6,302	$238,692
2020	710	5,990	$221,697
2021	596	7,861	$275,377
2022	493	4,868	$173,798
2023	392	6,361	$178,066
2024	403	5,369	$151,174

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	245	629	$231,742
2016	276	707	$619,755
2017	273	701	$147,524
2018	291	782	$211,275
2019	312	812	$121,620
2020	294	733	$99,923
2021	263	805	$75,631
2022	282	748	$89,829
2023	250	633	$74,193
2024	236	591	$44,724

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	142	142	$211
43248	Insertion of guide wire with dilation of esophagus using a flexible endoscope	34	36	$104
45380	Biopsy of large bowel using a flexible endoscope	84	84	$78
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	35	35	$70
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	109	112	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	40	1,292	$22,711
Clenpiq	Sod Picosulf/Mag Ox/Citric Ac	22	29	$3,711
Sutab	Sod Sulf/Pot Chloride/Mag Sulf	20	26	$3,027
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	38	49	$2,614
Pantoprazole Sodium	Pantoprazole Sodium	307	9,953	$2,135

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$211	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David L. Kerstetter, M.D.?

Tedicare shows public-source Medicare data for David L. Kerstetter, M.D. (NPI 1619994076), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David L. Kerstetter, M.D. have ACO affiliation data?

David L. Kerstetter, M.D. is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019) and AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to David L. Kerstetter, M.D.?

David L. Kerstetter, M.D. is linked to REGIONAL GASTROENTEROLOGY ASSOCIATES OF LANCASTER, LTD. (billing NPI 1154422806) in the available physician profile data.

Does David L. Kerstetter, M.D. have Open Payments data?

David L. Kerstetter, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.